Выбор редакции

There's Value in Studying Big Pharma Pipelines

When analysts review a big pharma’s future prospects, they rightly focus on those drugs that are in the last stage of clinical trials (phase 3). These are the compounds for which the most is known and whose clinical programs are spelled out in detail on ClinicalTrials.gov. While not every compound [...]

НОВОСТИ ПО ТЕМЕ